# Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy

> **NCT00474838** · PHASE4 · COMPLETED · sponsor: **Kyunghee University Medical Center** · enrollment: 112 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Pancreatic Beta Cell Function
- Glucotoxicity

## Interventions

- **DRUG:** intensive insulin group
- **DRUG:** Oral AntiDiabetic Drug (glimepiride and metformin)

## Key facts

- **NCT ID:** NCT00474838
- **Lead sponsor:** Kyunghee University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2013-09-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474838, "Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00474838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*